Company profile: Bardy Diagnostics
1.1 - Company Overview
Company description
- Provider of cardiac monitoring and arrhythmia detection solutions, including the CAM Patch, a lightweight, extended-wear cardiac patch that optimizes P-wave capture for up to 14 days of continuous ECG monitoring; the BDxCONNECT Portal for secure ECG data upload, analysis, and full report delivery; and the CAM Report offering clear, full-disclosure ECG interpretations typically within 48 hours. CAM can be worn during exercise or while showering.
Products and services
- BDxCONNECT Portal: A secure web-based patient management portal that enables upload and analysis of patient ECG data, producing full disclosure reports accessible online
- CAM Patch: An extended-wear cardiac patch monitor that optimizes P-wave signal capture, enabling up to 14 days of continuous ECG monitoring and wear during exercise or showering
- CAM Report: A proprietary-format ECG report that delivers clear, concise full disclosure enabling quick, in-depth interpretations of ECG data, typically available within 48 hours after data upload
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bardy Diagnostics
InterVene
HQ: United States
Website
- Description: Provider of minimally invasive medical devices and therapies for chronic venous disease, particularly deep vein valve failure. The company's BlueLeaf™ Endovenous Valve Formation System offers a non-implantable solution to address severe venous conditions in the legs, aiming to improve patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InterVene company profile →
Vascular Pathways
HQ: United States
Website
- Description: Provider of vascular access medical devices, manufacturing the AccuCath Intravenous Catheter and commercializing the FDA-cleared Rapid IntraVascular Start (RIVS) catheter, which enables rapid, safe and successful peripheral IV insertion.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Pathways company profile →
CorWave
HQ: France
Website
- Description: Provider of biomimetic heart pumps and cardiac support devices, including the CorWave LVAD for advanced heart failure that uses an undulating disc wave mechanism to deliver pulsatile, physiological blood flow with less blood trauma, reducing clotting and bleeding complications; Nemo, a compact, minimally invasive device for partial heart failure support; and Wave Membrane Technology enabling physiological flow and pulsatility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CorWave company profile →
Omeicos
HQ: Germany
Website
- Description: Provider of first-in-class small-molecule therapeutics based on omega-3 fatty acid metabolites for the treatment and prevention of atrial fibrillation and broader indications. Offers OMT-28, a synthetic analog of 17,18-EEQ for cardiovascular inflammation and mitochondrial dysfunction; conducts the PMD-OPTION study in Primary Mitochondrial Disease; and develops a pipeline of proprietary omega-3 analogs for cardiovascular, inflammatory, and mitochondrial diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omeicos company profile →
CardioGenics
HQ: Turkey
Website
- Description: Provider of sensitive diagnostic test products to the IVD market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioGenics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bardy Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bardy Diagnostics
2.2 - Growth funds investing in similar companies to Bardy Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bardy Diagnostics
4.2 - Public trading comparable groups for Bardy Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →